A study of high-nuclear-grade breast cancer in Thailand: subclassification and correlation with prognostic factors and immunohistochemical study

被引:4
作者
Chaiwun, Benjaporn [1 ]
Nakrungsee, Saranyu [1 ]
Sukhamwang, Neelaya [1 ]
Srisukho, Songphol [2 ]
机构
[1] Chiang Mai Univ, Fac Med, Dept Pathol, Chiang Mai 50200, Thailand
[2] Chiang Mai Univ, Fac Med, Dept Surg, Chiang Mai 50200, Thailand
关键词
Grade; Invasive breast carcinoma; Atypical medullary carcinoma; Medullary carcinoma; Triple-negative; Immunohistochemistry; MOLECULAR PORTRAITS; HISTOLOGIC GRADE; BASAL; CARCINOMAS; PHENOTYPE; STAGE;
D O I
10.1007/s12282-009-0174-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Objectives To classify high-nuclear-grade breast cancer (BC) into typical medullary carcinoma (TMC), atypical medullary carcinoma (AMC), and non-medullary carcinoma (NMC), and luminal A, luminal B, and HER2, and to correlate these tumors with other prognostic factors. Materials and methods A retrospective study reviewing high-nuclear-grade BCs. The patients' age, histologic types, various histologic features, axillary lymph node (ALN) status, and results of immunohistochemical (IHC) study were recorded and analyzed. Results One-hundred and eighty-one cases of high-nuclear-grade BCs were reviewed and categorized into IDC, NOS (140, 77.3%), TMC (1, 0.6%), AMC (21, 11.6%), and others (19, 10.5%). The median age was younger in AMC than in NMC patients. NMC patients had a higher incidence of LVI and ALN metastasis with involvement of more than four lymph nodes (p = 0.006) whereas AMC patients had a higher mitotic index. Forty-six (35.9%) cases were triple-negative (TN), including 1 (100%), 7 (53.9%) and 38 (33.3%) cases of TMC, AMC, and NMC, respectively. AMC had a significantly lower number of node metastases (p = 0.006) than NMC; whereas TN had higher MI (p = 0.001) than non-TN. The non-TN group was subclassified into luminal A, luminal B, and HER2. Of these, TN and luminal B occurred at younger age (p = 0.01) whereas TN and luminal A had a higher mitotic count. TN had lower incidence of LNM including higher number of LNM. Conclusion Overall, AMC-TN group showed a basal-like prognostic factor expression. NMC may be separated into TN and non-TN, with possibly different behavior. These sub-groupings should continue to be used. Interestingly, luminal A in our study tended to correlate with poor prognostic factors, thus, luminal A with high nuclear grade may not be representative of the usual luminal group profiles.
引用
收藏
页码:35 / 41
页数:7
相关论文
共 30 条
[1]
How basal are triple-negative breast cancers? [J].
Bertucci, Francois ;
Finetti, Pascal ;
Cervera, Nathalie ;
Esterni, Benjamin ;
Hermitte, Fabienne ;
Viens, Patrice ;
Birnbaum, Daniel .
INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (01) :236-240
[2]
Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers [J].
Bertucci, Francois ;
Finetti, Pascal ;
Cervera, Nathalie ;
Charafe-Jauffret, Emmanuelle ;
Mamessier, Emilie ;
Adelaide, Jose ;
Debono, Stephane ;
Houvenaeghel, Gilles ;
Maraninchi, Dominique ;
Viens, Patrice ;
Charpin, Colette ;
Jacquemier, Jocelyne ;
Birnbaum, Daniel .
CANCER RESEARCH, 2006, 66 (09) :4636-4644
[3]
Does triple-negative phenotype accurately identify basal-like turnour?: An immunohistochemical analysis based on 143 'triple-negative' breast cancers [J].
Bidard, F.-C. ;
Conforti, R. ;
Boulet, T. ;
Michiels, S. ;
Delaloge, S. ;
Andre, F. .
ANNALS OF ONCOLOGY, 2007, 18 (07) :1285-1286
[4]
HISTOLOGICAL GRADING AND PROGNOSIS IN BREAST CANCER - A STUDY OF 1409 CASES OF WHICH 359 HAVE BEEN FOLLOWED FOR 15 YEARS [J].
BLOOM, HJG ;
RICHARDSON, WW .
BRITISH JOURNAL OF CANCER, 1957, 11 (03) :359-&
[5]
PATHOLOGICAL PROGNOSTIC FACTORS IN BREAST-CANCER .1. THE VALUE OF HISTOLOGICAL GRADE IN BREAST-CANCER - EXPERIENCE FROM A LARGE STUDY WITH LONG-TERM FOLLOW-UP [J].
ELSTON, CW ;
ELLIS, IO .
HISTOPATHOLOGY, 1991, 19 (05) :403-410
[6]
Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast [J].
Fulford, L. G. ;
Easton, D. F. ;
Reis-Filho, J. S. ;
Sofronis, A. ;
Gillett, C. E. ;
Lakhani, S. R. ;
Hanby, A. .
HISTOPATHOLOGY, 2006, 49 (01) :22-34
[7]
GALLAGER HS, 1984, CANCER, V53, P623, DOI 10.1002/1097-0142(19840201)53:3+<623::AID-CNCR2820531307>3.0.CO
[8]
2-Z
[9]
Gamel JW, 1996, CANCER, V77, P1459, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1459::AID-CNCR6>3.0.CO
[10]
2-7